SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-14-085967
Filing Date
2014-12-10
Accepted
2014-12-10 16:37:59
Documents
5
Period of Report
2014-12-07
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a14-25952_18k.htm 8-K 24653
2 EX-99.1 a14-25952_1ex99d1.htm EX-99.1 17972
3 EX-99.2 a14-25952_1ex99d2.htm EX-99.2 17870
4 GRAPHIC g259521mmi001.jpg GRAPHIC 3463
5 GRAPHIC g259521moi001.jpg GRAPHIC 3463
  Complete submission text file 0001104659-14-085967.txt   71595
Mailing Address 375 PHEASANT RUN NEWTOWN PA 18940
Business Address 375 PHEASANT RUN NEWTOWN PA 18940 267-759-3681
Onconova Therapeutics, Inc. (Filer) CIK: 0001130598 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36020 | Film No.: 141278391
SIC: 2834 Pharmaceutical Preparations